SW · Healthcare

Galderma Group N (GALD)

Drug Manufacturers - Specialty & Generic

Galderma Group N (GALD) is listed on SW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $37.21B, P/E ratio is 78.15, net margin is 11.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GALD

Market cap

$37.21B

P/E ratio

78.15

Gross profit (TTM)

$3.61B

Net margin

11.7%

Galderma Group N (GALD) — FAQ

What is Galderma Group N's market cap?

Galderma Group N (GALD) has a reported market cap of $37.21B (data as of 2026-05-24).

What is GALD's P/E ratio?

The price-to-earnings (P/E) ratio for Galderma Group N (GALD) is 78.15 (data as of 2026-05-24).

Does Galderma Group N pay a dividend?

Dividend yield is not available in the current snapshot for Galderma Group N (GALD). Check the MyAverix Finance app for the latest dividend data.

What sector is Galderma Group N in?

Galderma Group N (GALD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is GALD listed on?

GALD is listed on SW.

What is Galderma Group N's net margin?

Galderma Group N (GALD) reports a net margin of 11.7% (data as of 2026-05-24).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)